MedicineCancer BiologyOncologyMetastasisMolecular OncologyTumor ProgressionCancer ProgressionCancer Stem Cell BiologyMicrorna BiologyMicrorna-mediated RegulationPancreatic CancerStem Cell TumorigenicityCancer Stem Cell ProliferationCell Survival AssaysClonogenic Survival AssaysMicrorna Function In CancerMicrorna In CancerMicrorna In Stem Cell RegulationMicrorna Regulation In CancerReal-time Polymerase Chain Reaction (Pcr)
INTRODUCTION: Cancer stem cells (CSCs) are believed to be 'seed cell' in cancer recurrence and metastasis. MicroRNAs (miRNAs) have emerged as potential therapeutic candidates due to their ability to regulate multiple targets involved in tumor progression and chemoresistance. The goal of this study was to investigate the role of miRNA-200c (miR-200c) in regulating colony formation, invasion and chemoresistance of human pancreatic cancer stem cells (PCSCs). METHODS: PCSCs with CD24(+)CD44(+)ESA(+) as the marker was sorted from PANC-1 cell line by fluorescence activated cell sorter (FACS). Quantitative real-time PCR (qRT-PCR) assay was used to detect the expression of miR-200c in PCSCs and PANC-1 cells. Transfection of miR-200c mimic into PCSCs was performed to establish miR-200c over-expressed cells. The effects of overexpressing miR-200c on PCSCs were examined by cell colony forming, invasion and survival assays in vitro. RESULTS: Our data showed that CD24(+)CD44(+)ESA(+) PCSCs (0.5%) were isolated from PANC-1 cells. Expression of miR-200c was significantly reduced in PCSCs compared with PANC-1 cells. In addition, the capability of colony formation, invasion and chemoresistance were markedly increased in PCSCs than that in PANC-1 cells. Adverse results were obtained in miR-200c overexpressing PCSCs transfected with miR-200c mimic. CONCLUSION: Our study demonstrated that miR-200c overexpression could decrease colony formation, invasion and chemoresistance of PCSCs. It may become a new therapeutic target for gene therapy in patients suffered from pancreatic cancer.
11
Ahmedin Jemal, Rebecca L. Siegel, Jiaquan Xu et al. · CA A Cancer Journal for Clinicians · 2010 · 12.6K citations · Full text
Trastuzumab-Induced Hepatotoxicity: A Case Report
D. Vucicevic, Elizabeth J. Carey, Nina J. Karlin · Breast Care · 2013 · 4.4K citations · Full text
Medicine, Oncology, Pharmacotherapy +17
Pepijn Brocken, P.N.R. Dekhuijzen, Liesbeth Peters-Bax et al. · Respiration · 2013 · 4K citations · Full text
Characterization of clonogenic multiple myeloma cells
William Matsui, Carol Ann Huff, Qiuju Wang et al. · Blood · 2003 · 792 citations · Full text
Medicine, Cell Biology, Oncology +12
Liana Adam, Meng Zhong, Woonyoung Choi et al. · Clinical Cancer Research · 2009 · 408 citations · Full text